ADCT – adc therapeutics sa common shares (US:NASDAQ)

News

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
ADC Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference [Yahoo! Finance]
ADC Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference
ADC Therapeutics SA (NYSE: ADCT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com